2017 BIO International Convention

30, Jun 2017

Holy Stone Healthcare Co., Ltd., together with representatives of MDT Int’l S.A., attended 2017 BIO International Convention in San Diego, USA. on June 19-22.

During the exhibition, our two major developing products, IBD98-M & CA102N, were introduced. IBD98-M is a combination drug to treat mild to moderate Ulcerative Colitis, and CA102N is an anti-cancer drug-conjugate for targeted delivery to malignant cells. MDT Int’l also exhibited its medical devices products.

previous page